Visualization of ischemic stroke-related changes on 18 F-THK-5351 positron emission tomography

EJNMMI Research
Kuo-Lun HuangTsong-Hai Lee

Abstract

The 18F-THK-5351 radiotracer has been used to detect the in vivo tau protein distribution in patients with tauopathy, such as Alzheimer's disease and corticobasal syndrome. In addition, 18F-THK-5351 can also monitor neuroinflammatory process due to high affinity to astrogliosis. We aimed to explore 18F-THK-5351 distribution patterns and characteristics in patients with recent ischemic stroke. Fifteen patients received 18F-THK-5351 positron emission tomography (PET) and diffusion tensor imaging (DTI) approximately 3 months after ischemic stroke. A region of interest (ROI) was placed in the peri-ischemic area and was mirrored on the contralateral side as the control, and a proportional value was derived from the ratio of the peri-ischemic ROI value over the mirrored ROI value. Increased 18F-THK-5351 retention was observed in the areas around and remote from the stroke location. The proportional 18F-THK-5351 values were negatively correlated with the proportional fractional anisotropy values (r = - 0.39, P = 0.04). 18F-THK-5351 PET imaging provides a potential tool for in vivo visualization of the widespread ischemia-related changes associated with a microstructural disruption in recent ischemic stroke patients.

References

Sep 6, 2002·Journal of Alzheimer's Disease : JAD·C HesseK Blennow
Aug 15, 2009·Journal of Neuropathology and Experimental Neurology·Kazuaki IchiharaTomohiko Mizutani
May 18, 2010·The American Journal of Pathology·Maya A KoikeFrank M Laferla
Jun 16, 2010·Journal of Molecular Neuroscience : MN·Joanna BielewiczHalina Bartosik-Psujek
Aug 20, 2010·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Alexander ThielJeffrey Minuk
Aug 10, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Sonia LavisseCarole Escartin
May 21, 2013·Stroke; a Journal of Cerebral Circulation·Yael D ReijmerUNKNOWN Utrecht Vascular Cognitive Impairment Study Group
Jan 28, 2014·Neuron·Joshua E Burda, Michael V Sofroniew
Oct 8, 2014·Physiological Reviews·Milos Pekny, Marcela Pekna
Oct 30, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Hervé BoutinWilliam Trigg
Feb 7, 2015·Neural Regeneration Research·Shinghua Ding
Nov 3, 2015·Biochimica Et Biophysica Acta·Alba SimatsJoan Montaner
Nov 7, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Ryuichi HaradaYukitsuka Kudo
Nov 19, 2015·Stroke; a Journal of Cerebral Circulation·Ramesh SahathevanAmy Brodtmann
Oct 26, 2016·Brain Research Bulletin·Thomas ArendtMax Holzer
Nov 20, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Tobey J BetthauserBradley T Christian
Feb 12, 2017·Neurology·Samuel N LockhartWilliam J Jagust
Feb 22, 2017·Molecular Neurodegeneration·Laure Saint-AubertAgneta Nordberg
Mar 25, 2017·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Ing-Tsung HsiaoJung-Lung Hsu
Apr 1, 2017·Alzheimer's Research & Therapy·Kok Pin NgPedro Rosa-Neto
Apr 20, 2017·Frontiers in Molecular Neuroscience·Andrea Becerra-Calixto, Gloria P Cardona-Gómez
Sep 3, 2017·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Ryuichi HaradaNobuyuki Okamura

❮ Previous
Next ❯

Citations

Mar 5, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Christos TapeinosGianni Ciofani
Oct 19, 2020·Journal of Neuroinflammation·Kuo-Lun HuangKun-Ju Lin
Jul 11, 2020·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Ryuichi HaradaNobuyuki Okamura

❮ Previous
Next ❯

Software Mentioned

SPM8
ExploreDTI
SAS

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.